Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000670274 | SCV000795108 | uncertain significance | Usher syndrome type 1F | 2017-10-27 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV001195251 | SCV001365558 | uncertain significance | not specified | 2019-07-30 | criteria provided, single submitter | clinical testing | The p.Ile1940dup variant in PCDH15 has not been previously reported in individuals with hearing loss or Usher syndrome but has been identified in 0.006% (2/34500) of Latino chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant has also been reported in ClinVar (Variation ID 545502). This variant is a duplication of the isoleucine (Ile) residue at position 1940 and is not predicted to alter the protein reading-frame. It is unclear if this duplication will impact the protein. In summary, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PM2, PM4_Supporting. |
Labcorp Genetics |
RCV001226372 | SCV001398684 | uncertain significance | not provided | 2022-08-10 | criteria provided, single submitter | clinical testing | This variant, c.5818_5820dup, results in the insertion of 1 amino acid(s) of the PCDH15 protein (p.Ile1940dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs750168790, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with PCDH15-related conditions. ClinVar contains an entry for this variant (Variation ID: 554605). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |